Trials / Recruiting
RecruitingNCT04347200
REGistry of Long-term AnTithrombotic TherApy-1
Registry Dedicated to Assess the Risk of Ischemic and Hemorrhagic Complications of Long-term Antithrombotic Therapy in Patients With Chronic Coronary Syndromes
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- National Medical Research Center for Cardiology, Ministry of Health of Russian Federation · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To assess the rates of ischemic and hemorrhagic complications of long-term antithrombotic therapy in patients with chronic coronary syndromes
Detailed description
The register is a Russian prospective single-center observational study of patients who have indications for long-term antithrombotic therapy in connection with chronic coronary syndromes
Conditions
- Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))
- Peripheral Artery Disease
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Antiplatelet Drug | single or dual antiplatelets, triple antithrombotic therapy |
Timeline
- Start date
- 2015-01-15
- Primary completion
- 2026-01-31
- Completion
- 2026-01-31
- First posted
- 2020-04-15
- Last updated
- 2025-03-18
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT04347200. Inclusion in this directory is not an endorsement.